We are live on ! Find out more
CGEM icon

Cullinan Oncology
CGEM

97 hedge funds and large institutions have $396M invested in Cullinan Oncology in 2022 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 22 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

333% more call options, than puts

Call options by funds: $13K | Put options by funds: $3K

95% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 22

1.19% more ownership

Funds ownership: 81.18% → 82.37% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

2% less funds holding

Funds holding: 99 → 97 (-2)

15% less capital invested

Capital invested by funds: $467M → $396M (-$70.4M)

Holders
97
Holders Change
-2
Holders Change %
-2.02%
% of All Funds
1.56%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
12
Increased
43
Reduced
22
Closed
13
Calls
$13K
Puts
$3K
Net Calls
+$10K
Net Calls Change
-$492K

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$2.38M
2
American Century Companies
American Century Companies
Missouri
+$2.27M
3
TCM
Tang Capital Management
California
+$2.25M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.75M
5
BlackRock
BlackRock
New York
+$1.6M

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$5.51M
2
Goldman Sachs
Goldman Sachs
New York
-$1.93M
3
EC
EcoR1 Capital
California
-$1.31M
4
Morgan Stanley
Morgan Stanley
New York
-$768K
5
Marshall Wace
Marshall Wace
United Kingdom
-$520K
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
26
Woodline Partners
California
$2.07M +$2.38M +195,839 New
Goldman Sachs
27
Goldman Sachs
New York
$1.77M -$1.93M -158,860 -49%
PHP
28
Parkman Healthcare Partners
Connecticut
$1.39M +$1.6M +131,378 New
AQR Capital Management
29
AQR Capital Management
Connecticut
$1.17M +$35.9K +2,958 +3%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.15M +$38.1K +3,133 +3%
AI
31
Atom Investors
Texas
$1.13M +$320K +26,322 +33%
Norges Bank
32
Norges Bank
Norway
$1.08M – – –
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.05M +$270K +22,261 +29%
UBS Group
34
UBS Group
Switzerland
$1.04M +$86.1K +7,086 +8%
N
35
Nuveen
North Carolina
$978K -$177K -14,604 -14%
Fidelity Investments
36
Fidelity Investments
Massachusetts
$932K -$500K -41,148 -32%
Assenagon Asset Management
37
Assenagon Asset Management
Luxembourg
$876K +$1.01M +83,010 New
HS
38
HighVista Strategies
Massachusetts
$843K – – –
Bank of America
39
Bank of America
North Carolina
$737K +$84.2K +6,930 +11%
Ameriprise
40
Ameriprise
Minnesota
$631K +$727K +59,832 New
VRS
41
Virginia Retirement Systems
Virginia
$565K +$142K +11,700 +28%
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$493K +$11.1K +911 +2%
Victory Capital Management
43
Victory Capital Management
Texas
$443K – – –
MAM
44
Martingale Asset Management
Massachusetts
$439K +$129K +10,613 +34%
SSA
45
Schonfeld Strategic Advisors
New York
$359K +$413K +34,000 New
Swiss National Bank
46
Swiss National Bank
Switzerland
$348K +$25.5K +2,100 +7%
AllianceBernstein
47
AllianceBernstein
Tennessee
$298K +$18.2K +1,500 +6%
SFG
48
SVB Financial Group
Texas
$285K +$328K +27,032 New
Wellington Management Group
49
Wellington Management Group
Massachusetts
$284K +$6.77K +557 +2%
BC
50
Birchview Capital
Vermont
$265K – – –
1
2
3 4 5

CGEM Hedge Fund Activity: Q4 2022 in Review

97 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Cullinan Oncology (CGEM) for Q4 2022, worth a combined $396M — down 15% from $467M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CGEM and 12 opened new positions — a net loss of 1 holder — while 22 trimmed existing stakes and 43 added.

The largest buyer was Woodline Partners, opening a new position worth an estimated $2.38M. The largest seller was Baupost Group, exiting entirely with an estimated $5.51M sold.

  • 97 institutional investors held Cullinan Oncology (CGEM) as of Q4 2022, down from 99 in Q3 2022.
  • Funds reported $396M of Cullinan Oncology stock for Q4 2022, down 15% quarter-over-quarter.
  • 12 funds opened new Cullinan Oncology positions in Q4 2022 and 13 closed out, a net change of -1 holder.
  • The largest Cullinan Oncology buyer in Q4 2022 was Woodline Partners, an estimated $2.38M added.
  • The largest Cullinan Oncology seller in Q4 2022 was Baupost Group, an estimated $5.51M sold.

Based on aggregated 13F filings for Q4 2022.